Jatenzo 237 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FJXCX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,264
Award facts
- Contract value 100% obligated
- $2,263.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded June 16, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 120 capsules of Jatenzo 237 mg at a firm fixed price of $2,263.74, with an ultimate completion date of June 17, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. No set-aside designation was used for this award, indicating it was competitively procured. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a registered System for Award Management (SAM.gov) vendor, the company demonstrates extensive capability in fulfilling federal medical supply needs through its consistent delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's contract history with DLA reflects its proven ability to compete successfully in open market procurements and manage both small-value transactions and substantial orders exceeding $45,000, showcasing its versatility in supporting military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FJXCX?
SPE2DB25FJXCX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 16, 2025.
How much is contract SPE2DB25FJXCX worth?
The government has obligated $2,264 on SPE2DB25FJXCX.
Is contract SPE2DB25FJXCX an order under another contract?
Yes. SPE2DB25FJXCX is a delivery order under SPE2DB24D2217, an indefinite delivery contract.
Was contract SPE2DB25FJXCX competed?
The extent of competition for SPE2DB25FJXCX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award